Health Condition 1: L209- Atopic dermatitis, unspecified
Conditions
Interventions
Intervention1: Probiotics (Lactobacillus rhamnosus GG) with topical corticosteroid and emollient: Tablet/sachet form, oral probiotic (Lactobacillus rhamnosus GG) 6 billion CFU twice daily for 3 months
Sponsors
RESEARCH CELL ALL INDIA INSTITUTE OF MEDICAL SCIENCES JODHPUR
Eligibility
Inclusion criteria
Inclusion criteria: Clinically diagnosed cases of atopic dermatitis (U.K. Working Party diagnostic criteria) Patient with SCORAD of Patients whose parents or legal representative signed the written informed consent Treatment wash off period of atleast 2 months for systemic corticosteroids and immunosuppressants
Exclusion criteria
Exclusion criteria: Patient with chronic underlying disease (uncontrolled diabetes mellitus, uncontrolled hypertension, active tuberculosis) or is on immunosuppressive therapy. Children with severe hepatic, renal or other systemic disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Change in SCORAD Timepoint: 1. Change in SCORAD at 0 and 12 week | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. IL-31 level value change 2. Number of replapses 3. Adverse event if anyTimepoint: 1. IL-31 at 0 and 12 week 2. Relapses - Need for topical corticosteroid therapy with duration in follow up 3. Adverse event at each visit | — |
Countries
India
Contacts
Public ContactDr Nazneen Bano
ALL INDIA INSTITUTE OF MEDICAL SCIENCES, JODHPUR
Outcome results
None listed